Prior to P1 we would hope that each increased dosage would provide an incremental benefit. The results match expectations. If we were t assume little or on efficacy then analytically you would expect a mix bag of results and irregular rates of decline. Nothing of that nature was evident in the findings from 4 small but independent "trials".
When results are as expected with no adverse effects and an unqualified safety record only 1 conclusion can be reached in my mind.....as Sweet would say:
"There's got to be a way
To BlockBuster!."
Prior to P1 we would hope that each increased dosage would...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.90M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.0¢ | 20.0¢ | $191.1K | 906.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1300 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 9563 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
21.0¢ |
Change
0.000 ( 6.67 %) |
||||
| Open | High | Low | Volume | ||
| 22.0¢ | 22.5¢ | 20.5¢ | 533029 | ||
| Last updated 15.54pm 03/05/2024 ? | |||||
| PAA (ASX) Chart |